[go: up one dir, main page]

SI1553985T1 - Bifenili kot sredstva za slikanje pri Alzheimerjevi bolezni - Google Patents

Bifenili kot sredstva za slikanje pri Alzheimerjevi bolezni

Info

Publication number
SI1553985T1
SI1553985T1 SI200332079T SI200332079T SI1553985T1 SI 1553985 T1 SI1553985 T1 SI 1553985T1 SI 200332079 T SI200332079 T SI 200332079T SI 200332079 T SI200332079 T SI 200332079T SI 1553985 T1 SI1553985 T1 SI 1553985T1
Authority
SI
Slovenia
Prior art keywords
biphenyls
alzheimer
disease
imaging agents
amyloid deposits
Prior art date
Application number
SI200332079T
Other languages
English (en)
Inventor
Hank F Kung
Mei Ping Kung
Zhi-Ping Zhang
Original Assignee
Univ Pennsylvania
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Pennsylvania filed Critical Univ Pennsylvania
Publication of SI1553985T1 publication Critical patent/SI1553985T1/sl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/51Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/60Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton with the carbon atom of at least one of the carboxyl groups bound to nitrogen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04Organic compounds
    • A61K51/0474Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
    • A61K51/0478Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group complexes from non-cyclic ligands, e.g. EDTA, MAG3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/23Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
    • C07C323/24Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/25Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/16Halogen atoms or nitro radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F13/00Compounds containing elements of Groups 7 or 17 of the Periodic Table
    • C07F13/005Compounds without a metal-carbon linkage

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physics & Mathematics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
SI200332079T 2002-10-04 2003-10-06 Bifenili kot sredstva za slikanje pri Alzheimerjevi bolezni SI1553985T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US41582402P 2002-10-04 2002-10-04
EP03808140A EP1553985B1 (en) 2002-10-04 2003-10-06 Biphenyls as imaging agents in alzheimer's disease
PCT/US2003/031466 WO2004032975A2 (en) 2002-10-04 2003-10-06 Biphenyls and fluorenes as imaging agents in alzheimer's disease

Publications (1)

Publication Number Publication Date
SI1553985T1 true SI1553985T1 (sl) 2012-01-31

Family

ID=32093786

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200332079T SI1553985T1 (sl) 2002-10-04 2003-10-06 Bifenili kot sredstva za slikanje pri Alzheimerjevi bolezni

Country Status (11)

Country Link
US (1) US20050271584A1 (sl)
EP (1) EP1553985B1 (sl)
JP (1) JP2006502220A (sl)
AT (1) ATE522230T1 (sl)
AU (1) AU2003277280A1 (sl)
DK (1) DK1553985T3 (sl)
ES (1) ES2370818T3 (sl)
PT (1) PT1553985E (sl)
SI (1) SI1553985T1 (sl)
TW (1) TW200413009A (sl)
WO (1) WO2004032975A2 (sl)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007002540A2 (en) * 2005-06-24 2007-01-04 Kung Hank F Radiolabeled-pegylation of ligands for use as imaging agents
JP4738419B2 (ja) 2005-11-30 2011-08-03 富士フイルムRiファーマ株式会社 アミロイドの凝集及び/又は沈着に起因する疾患の診断薬及び治療薬
WO2008118122A2 (en) * 2006-05-08 2008-10-02 Molecular Neuroimaging, Llc Compounds and amyloid probes thereof for therapeutic and imaging uses
WO2008124812A1 (en) * 2007-04-10 2008-10-16 The Trustees Of The University Of Pennsylvania Phen-naphthalene and phen-quinoline derivatives and their use for binding and imaging amyloid plaques
JP2010524965A (ja) * 2007-04-19 2010-07-22 ザ・トラスティーズ・オブ・ザ・ユニバーシティ・オブ・ペンシルバニア ジフェニル−ヘテロアリール誘導体並びにアミロイド斑への結合及び画像化のためのその使用
JP2011514343A (ja) * 2008-02-27 2011-05-06 アビッド レディオファーマシューティカルズ、インク. 放射線標識a−ベータ結合化合物を用いたアミロイドプラークのガンマプローブ検出
US8557222B2 (en) * 2008-04-04 2013-10-15 Avid Radiopharmaceuticals, Inc. Radiopharmaceutical imaging of neurodegenerative diseases
EP2300481B1 (en) 2008-05-30 2015-09-30 Merck Sharp & Dohme Corp. Novel substituted azabenzoxazoles
KR101787112B1 (ko) * 2008-06-09 2017-11-15 루드비히-막시밀리안스-우니버지테트 뮌헨 신경변성 질환 및/또는 단백질 응집과 연관된 질환과 관련된 단백질의 응집을 억제하기 위한 신규 약물
CN102256959B (zh) * 2008-10-17 2014-01-08 比奥克罗密克斯药业有限公司 用于治疗的噻吩化合物
WO2010056900A1 (en) * 2008-11-13 2010-05-20 Avid Radiopharmaceuticals, Inc. Histogram-based analysis method for the detection and diagnosis of neurodegenerative diseases
KR101101977B1 (ko) * 2009-04-09 2012-01-02 (주)에스메디 2-아릴나프탈렌, 2-아릴퀴놀린 유도체 또는 이의 약학적으로 허용가능한 염, 이의 제조방법 및 이를 유효성분으로 함유하는 퇴행성 뇌질환의 진단 또는 치료용 약학적 조성물
CN102557969B (zh) * 2011-11-01 2015-03-18 中国科学技术大学 环酮类衍生物及其作为淀粉样蛋白沉积物和神经纤维缠结的显像剂和聚集抑制剂的用途
JP2021501198A (ja) * 2017-10-27 2021-01-14 トランスフュージョン ヘルス,リミティド ライアビリティ カンパニー フルオレンの誘導体を用いて造血幹細胞を増殖する組成物および方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2157071A (en) * 1937-08-27 1939-05-02 Dow Chemical Co Alkyl ethers of meta-phenylphenol
GB1091403A (en) * 1964-01-24 1967-11-15 Boots Pure Drug Co Ltd Therapeutically active phenylalkane derivatives
AU545825B2 (en) * 1980-10-02 1985-08-01 Fmc Corporation Biphenylmethanols and derivatives thereof
US5034384A (en) * 1990-08-01 1991-07-23 Merck & Co., Inc. 2-(9-fluorenonyl)-carbapenem antibacterial agents
US5192753A (en) * 1991-04-23 1993-03-09 Mcgeer Patrick L Anti-rheumatoid arthritic drugs in the treatment of dementia
US6168776B1 (en) * 1994-07-19 2001-01-02 University Of Pittsburgh Alkyl, alkenyl and alkynyl Chrysamine G derivatives for the antemortem diagnosis of Alzheimer's disease and in vivo imaging and prevention of amyloid deposition
US5739166A (en) * 1994-11-29 1998-04-14 G.D. Searle & Co. Substituted terphenyl compounds for the treatment of inflammation
US5994379A (en) * 1998-02-13 1999-11-30 Merck Frosst Canada, Inc. Bisaryl COX-2 inhibiting compounds, compositions and methods of use

Also Published As

Publication number Publication date
ATE522230T1 (de) 2011-09-15
EP1553985B1 (en) 2011-08-31
EP1553985A2 (en) 2005-07-20
WO2004032975A3 (en) 2004-09-16
DK1553985T3 (da) 2011-12-12
AU2003277280A8 (en) 2004-05-04
AU2003277280A1 (en) 2004-05-04
JP2006502220A (ja) 2006-01-19
ES2370818T3 (es) 2011-12-23
PT1553985E (pt) 2011-11-30
TW200413009A (en) 2004-08-01
US20050271584A1 (en) 2005-12-08
WO2004032975A2 (en) 2004-04-22

Similar Documents

Publication Publication Date Title
WO2002085903A3 (en) Amyloid plaque aggregation inhibitors and diagnostic imaging agents
HK1110313A1 (en) Stilbene derivatives and their use for binding and imaging amyloid plaques
WO2007033080A3 (en) Alzheimer's disease imaging agents
AU2002225772A1 (en) Therapeutic agents and methods of use thereof for treating an amyloidogenic disease
MX2007007380A (es) Derivados de estilbeno y su uso para estudios de union y por imagenes de placas amiloides.
BR0210122A (pt) Composto ou um sal farmaceuticamente aceitável do mesmo, método para o tratamento ou prevenção de uma doença, uso do composto ou de seu sal, e, método para preparar o mesmo
HK1087398A1 (en) 1-phenylalkanecarboxylic acid derivatives for the treatment of neurodegenerative diseases
IL175158A0 (en) Tocopherol-modified therapeutic drug compounds
AU2003206413A8 (en) Substituted amino carboxamides for the treatment of alzheimer's disease
SI1553985T1 (sl) Bifenili kot sredstva za slikanje pri Alzheimerjevi bolezni
IL165696A0 (en) Substituted 1,3-diphenykprop-2-en-1-one derivatives and preparation and uses thereof
BR9814923A (pt) Método para tratamento de doença de alzheimer
MXPA04008068A (es) Metodo para administrar moleculas de glp-1.
GB0108592D0 (en) Therapeutic agents
HK1113970A1 (en) Formulations for injection of catecholic butanes, including ndga compounds, into animals
MXPA04002785A (es) Aminas sustituidas para tratamiento de enfermedad de alzheimer.
BR9914940A (pt) Método para aperfeiçoar a farmacocinética de tipranavir
AU2002315131A1 (en) Aminediols as agents for the treatment of alzheimer's disease
CR6528A (es) Metodo para inhibir la agregcion de proteinas amiloidesy formacion de imagenes de depositos amiloides
WO2006078384A3 (en) Stilbene derivatives and their use
AU2003303141A8 (en) Hydroxypropyl amides for the treatment of alzheimer's disease
MXPA03011502A (es) Aminoalcoholes sustituidos utiles en tratamiento de enfermedad de alzheimer.
AU2003273310A1 (en) Substituted aminoethers for the treatment of alzheimer's disease
WO2008057599A3 (en) Methods for the treatment of abeta related disorders and compositions therefor
UA66932C2 (en) Complex of eletriptan and sulphobutylether-beta-cyclodextrin, pharmaceutical composition, method for their manufacture and method for treating migraine